Nurse Practitioner · Naperville, IL
NPI
1538156567
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2007 95th St
Naperville, IL, 60564
Phone (630) 646-6920
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
165 services
Medicare patients, 2024
81
Average age 74
Drug cost, 2024
$55K
777 prescriptions
Company payments, 2025
$122
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer A Chludzinski was code 99213 (office e&m - established), 46 times for 39 patients. In total Jennifer A Chludzinski billed 165 services in 20 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 46 | 39 | $49.84 | $2,293 |
| 99214 Office E&M - Established | Office | 35 | 25 | $74.69 | $2,614 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 33 | 33 | $118.21 | $3,901 |
| 90662 Vaccine Product | Office | 11 | 11 | $81.82 | $900 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $33.45 | $368 |
By year: 2022 $9,488 for 134 services; 2023 $8,156 for 98 services; 2024 $12K for 165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer A Chludzinski prescribed most often to Medicare patients was Lisinopril, with 39 prescriptions and refills. In total Jennifer A Chludzinski wrote 777 Medicare prescriptions that cost $55K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 39 | 113 | 13 | $234 |
| Alprazolam Generic | 34 | 34 | Under 11 | $90.66 |
| Atorvastatin Calcium Generic | 32 | 96 | 13 | $237 |
| Rosuvastatin Calcium Generic | 30 | 81 | Under 11 | $204 |
| Levothyroxine Sodium Generic | 24 | 72 | Under 11 | $162 |
| Omeprazole Generic | 24 | 72 | Under 11 | $136 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 23 | 23 | Under 11 | $330 |
| Amlodipine Besylate Generic | 23 | 61 | Under 11 | $191 |
| Zolpidem Tartrate Generic | 22 | 34 | Under 11 | $78.55 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 19 | 57 | Under 11 | $364 |
| Bupropion Xl Bupropion Hcl | 18 | 54 | Under 11 | $352 |
| Sertraline Hcl Generic | 17 | 51 | Under 11 | $127 |
| Furosemide Generic | 17 | 35 | Under 11 | $38.33 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 16 | 48 | Under 11 | $202 |
| Trazodone Hcl Generic | 16 | 48 | Under 11 | $83.26 |
Brand drugs: 70 claims; generic drugs: 692 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer A Chludzinski $122 ($122 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $43.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.